Salvage PRRT with (177)Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

por Rudisile, S., Gosewisch, A., Wenter, V., Unterrainer, M., Böning, G., Gildehaus, F. J., Fendler, W. P., Auernhammer, C. J., Spitzweg, C., Bartenstein, P., Todica, A., Ilhan, H.
Publicado 2019

Diagnostic accuracy of SSR-PET/CT compared to histopathology in the identification of liver metastases from well-differentiated neuroendocrine tumors

por Fabritius, M. P., Soltani, V., Cyran, C. C., Ricke, J., Bartenstein, P., Auernhammer, C. J., Spitzweg, C., Schnitzer, M. L., Ebner, R., Mansournia, S., Hinterberger, A., Lohse, A., Sheikh, G. T., Winkelmann, M., Knösel, T., Ingenerf, M., Schmid-Tannwald, C., Kunz, W. G., Rübenthaler, J., Grawe, Freba
Publicado 2023